By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Tex Pat has filed separate lawsuits accusing Thermo Fisher Scientific and Agilent Technologies of false patent marking.

Both lawsuits were filed led yesterday in US District Court for the Eastern District of Texas, Texarkana Division, and accuses both Thermo Fisher and Agilent of continuing to mark expired patents on its products, which harms their competitors, as well as the general public, including Tex Pat, it said in its complaints.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.